Evidence map›Paper›PMID 32043182›Full record

ArticleJournal of assisted reproduction and genetics2020

Do serum progesterone levels on day of embryo transfer influence pregnancy outcomes in artificial frozen-thaw cycles?

Michelle Volovsky, Cassandra Pakes, Genia Rozen, Alex Polyakov

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04897269 phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

Effectiveness of Progesterone Supplementation for Women Having Low Progesterone Levels on the Day of Frozen Embryo Transfer

TypeinterventionalSponsorTu Du HospitalRan2021 to 2024Enrolled824ConditionsAssisted Reproductive TechnologyArmsProgesterone supplementation
NCT05758064 phase2 / phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

How to Rescue Hormonal Replacement Frozen Embryo Transfer Cycle With Low Serum Progesterone? A Randomized Control Trial.

TypeinterventionalSponsorEl Shatby University Hospital for Obstetrics and GynecologyRan2023 to 2023Enrolled120ConditionsHormonal Replacement Frozen Embryo Transfer CycleArmsDuphaston, prolutex
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Michelle VolovskyMaimonides Medical Center (OBGYN), New York, NY, USA. michelle.volovsky@gmail.com.ORCID http://orcid.org/0000-0003-1473-7225
Cassandra PakesRoyal Women's Hospital (OBGYN), Melbourne, VIC, Australia.
Genia RozenRoyal Women's Hospital (OBGYN), Melbourne, VIC, Australia.
Alex PolyakovRoyal Women's Hospital (OBGYN), Melbourne, VIC, Australia.
Royal Women's Hospital · AUMaimonides Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study is to investigate whether progesterone (P4) levels on the day of frozen-thawed embryo transfer (FET) to a hormonally prepared endometrium correlate with pregnancy outcomes.

methodsThis is a large retrospective cohort analysis comprising of N = 2010 FETs. In these cycles, P4 levels on the day of transfer were assessed in relation to pregnancy outcomes. A threshold of 10 ng/mL was used to simulate currently accepted levels for physiological corpus luteal function. Biochemical pregnancy, clinical pregnancy, and live birth rates were compared between those with P4 levels above and below this threshold. Analyses using transfer day P4 thresholds of 5 ng/mL and 20 ng/mL were then completed to see if these could create further prognostic power.

resultsWhen comparing FET outcomes in relation to P4 levels < 10 ng/mL and ≥ 10 ng/mL, we observed no differences in biochemical pregnancy rates (39.53% vs. 40.98%, p = 0.52), clinical pregnancy rates (20.82 vs. 22.78, p = 0.30), and live birth rates (14.25 vs. 16.21 p = 0.23). In patients whose P4 met the threshold of 20 ng/mL, there was similarly no statistically significant improvement in pregnancy outcomes. While there was no difference for biochemical or clinical pregnancy rates, a statistically significant improvement in live birth rates was observed for those with a transfer day P4 level ≥ 5 ng/mL.

conclusionsWe demonstrated that P4 levels at or above 10 ng/mL on the day of FET do not confer a statistically significant improvement in pregnancy outcomes. P4 below 5 ng/mg was associated with lower live birth rates suggesting that there is a threshold below which it is difficult to salvage FET cycles.

Indexed as

Fertilization in VitroAdultBirth RateCryopreservationEmbryo TransferFemaleHumansLive BirthPregnancyPregnancy OutcomeProgesteroneRetrospective StudiesProgesteroneAssisted reproductive technologyEmbryo transferFrozenProgesterone

Identifiers

PMID32043182
PMCPMC7244647
OpenAlexW3005697888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.